Ω-Agatoxin IVA
Ω-Agatoxin IVA is a peptide toxin derived from the venom of the funnel-web spider Agelenopsis aperta. This toxin is a potent and selective blocker of certain voltage-gated calcium channels, specifically the P/Q-type calcium channels, which are critical for neurotransmitter release in the central nervous system.
Structure and Function
Ω-Agatoxin IVA is a member of the agatoxin family of toxins, which are known for their ability to modulate ion channels. The structure of Ω-Agatoxin IVA consists of a complex arrangement of amino acids that form a stable three-dimensional conformation, allowing it to interact specifically with its target channels.
The primary function of Ω-Agatoxin IVA is to inhibit the P/Q-type calcium channels. These channels are predominantly found in the presynaptic terminals of neurons and are essential for the release of neurotransmitters. By blocking these channels, Ω-Agatoxin IVA effectively reduces synaptic transmission, which can be useful in studying the role of these channels in various physiological and pathological processes.
Mechanism of Action
Ω-Agatoxin IVA binds to the α1A subunit of the P/Q-type calcium channels, which are also known as Cav2.1 channels. This binding prevents the influx of calcium ions into the presynaptic terminal, thereby inhibiting the release of neurotransmitters such as glutamate and GABA. The blockade of these channels by Ω-Agatoxin IVA is highly specific and does not significantly affect other types of calcium channels, such as L-type or N-type channels.
Applications in Research
Due to its specificity, Ω-Agatoxin IVA is a valuable tool in neurophysiological research. It is used to:
- Study synaptic transmission: By selectively blocking P/Q-type calcium channels, researchers can investigate the role of these channels in neurotransmitter release and synaptic plasticity.
- Explore neurological disorders: Dysfunctions in P/Q-type calcium channels are implicated in various neurological disorders, including epilepsy and ataxia. Ω-Agatoxin IVA can be used to model these conditions in experimental settings.
- Develop therapeutic agents: Understanding how Ω-Agatoxin IVA interacts with calcium channels can aid in the design of new drugs targeting these channels for therapeutic purposes.
Safety and Handling
As a potent neurotoxin, Ω-Agatoxin IVA must be handled with care in a laboratory setting. Appropriate safety measures, including the use of personal protective equipment and proper disposal procedures, should be followed to prevent accidental exposure.
Also see
This toxin-related article is a stub. You can help WikiMD by expanding it.
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD